Galderma announced today positive topline results from the phase III READY3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of glabellar lines frown lines and lateral canthal lines crows feet either alone singlearea or simultaneously.
Results From Galderma's Phase IIIb Trials Demonstrate Rapid and Long-Lasting Effect of RelabotulinumtoxinA on Crow's Feet and Frown Lines finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Galderma announced today topline results from two phase IIIb trials investigating RelabotulinumtoxinA for the treatment of glabellar lines GL frown lines and lateral canthal lines LCL crows feet.